Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 18Gynecologic 12Breast 9Thoracic 6Genitourinary 3Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Dermatologic 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1Myeloid 1Endocrine 1Classical hematology 1

Conditions

Postural Orthostatic Tachycardia Syndrome 1Mastocytosis 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Cyclophosphamide 261fludarabine phosphate 233Azacitidine 182fludarabine 181Busulfan 176Cytarabine 155Imatinib Mesylate 152Mycophenolic Acid 148Tacrolimus 146Whole-Body Irradiation 142Peripheral Blood Stem Cell Transplantation 140Cyclosporine 110Antilymphocyte Serum 108Melphalan 107Methotrexate 105Filgrastim 101Decitabine 98nilotinib 94venetoclax 79ruxolitinib 79Dasatinib 68Granulocyte Colony-Stimulating Factor 66Stem Cell Transplantation 63Thiotepa 60Radiotherapy 60thymoglobulin 52Specimen Handling 49Etoposide 49Clofarabine 46Cord Blood Stem Cell Transplantation 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mass Screening × Myeloid × Clear all
NCT07143669 2026-05-22

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

Recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡